Fractional flow reserve based on computed tomography: an overview. (29th April 2016)

• Record Type: Journal Article
• Authors: Secchi, Francesco; Alì, Marco; Faggiano, Elena; Cannaò, Paola Maria; Fedele, Marco; Tresoldi, Silvia; Di Leo, Giovanni; Auricchio, Ferdinando; Sardanelli, Francesco
• Is Part Of: European heart journal supplements. Volume 18(2016)Supplement E
• Page Start: E49
• Page End: E56
• Publication Date: 2016-04-29
• Subjects: Coronary artery disease -- Fractional flow reserve -- Computed tomography -- Transluminal attenuation gradient; Cardiology -- Periodicals; Cardiology -- Europe -- Periodicals; 616.12005
• DOI: 10.1093/eurheartj/suw014
• Languages: English
• ISSNs: 1520-765X

Abstract

Abstract: Computed tomography coronary angiography (CTCA) is a technique proved to provide high sensitivity and negative predictive value for the identification of anatomically significant coronary artery disease (CAD) when compared with invasive X-ray coronary angiography. While the CTCA limitation of a ionizing radiation dose delivered to patients is substantially overcome by recent technical innovations, a relevant limitation remains the only anatomical assessment of coronary stenoses in the absence of evaluation of their functional haemodynamic significance. This limitation is highly important for those stenosis graded as intermediate at the anatomical assessment. Recently, non-invasive methods based on computational fluid dynamics were developed to calculate vessel-specific fractional flow reserve (FFR) using data routinely acquired by CTCA [computed tomographic fractional flow reserve (CT-FFR)]. Here we summarize methods for CT-FFR and review the evidence available in the literature up to June 26, 2016, including 16 original articles and one meta-analysis. The perspective of CT-FFR may greatly impact on CAD diagnosis, prognostic evaluation, and treatment decision-making. The aim of this review is to describe technical characteristics and clinical applications of CT-FFR, also in comparison with catheter-based invasive FFR, in order to make a cost–benefit balance in terms of clinical management and patient's health.